Preliminary data from the CDC show the US suicide rate decreased in 2024, falling to 13.7 per 100,000 people, from some of the highest levels previously recorded. Experts are unsure if this trend will continue, citing factors such as depression, limited mental health services and firearm availability. The rate dropped among people in their late 20s and early 30s, as well as in some Southern and Midwestern states. The Department of Veterans Affairs' screening programs and the 988 crisis line may have contributed to the decline in suicide, which is the nation's 10th leading cause of death.

Darwin's VISN Profiles deliver insider knowledge to help you navigate the VA with confidence. Developed with the same rigor as our IDN reports, each profile outlines key leaders, priorities, and affiliations across all 18 VISNs to drive market access success.

Walter Reed Hospital offers personalized diabetes management for military personnel, addressing the condition's impact on readiness and deployment. The hospital's approach includes nutrition, exercise and stress management, with specialized care for Type 1 and Type 2 diabetes. Deirdre Smith, an endocrinology nurse practitioner and a certified diabetic educator in Walter Reed's Department of Endocrinology, highlights the importance of glycemic control for deployment eligibility, while emphasizing the resources available within the Military Health System to support patients.

USAA's Face the Fight coalition is actively addressing Veteran suicide, a pressing issue among service members. Led by Chris Ford, the initiative has invested $42 million since 2023 to connect at-risk Veterans with mental health resources and promote firearm safety. With over 300 partners, the program also explores the link between financial issues and suicide, aiming to provide comprehensive support for Veterans.

A new study presented at the American Society of Hematology meeting reveals that Vietnam War Veterans exposed to Agent Orange have a higher risk of developing myelodysplastic syndrome, a rare bone marrow cancer. Led by Dr. Mikkael Sekeres from the University of Miami, the research shows that those exposed to the defoliant are diagnosed with MDS at younger ages and with more aggressive forms of the disease. The findings could aid Veterans in securing health care coverage for MDS treatment, particularly those affected by Agent Orange.

The FDA has introduced the Technology-Enabled Meaningful Patient Outcomes pilot program to accelerate the market entry of digital health technologies for chronic diseases. The program will work within the CMS' Advancing Chronic Care with Effective, Scalable Solutions model to improve access to health technologies for conditions such as high blood pressure, diabetes, chronic pain and depression. Up to 10 device manufacturers in four clinical areas will be selected to participate in the initiative, which will collect real-world performance data.